CF
CRBU icon

Corebridge Financial’s Caribou Biosciences CRBU Stock Holding History

Corebridge Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,304
Closed -$36.8K – 646
2025
Q1 		$36.8K Sell
40,304
-597
-1% -$776 ﹤0.01% 2800
2024
Q4 		$65K Sell
40,901
-3,088
-7% -$6.21K ﹤0.01% 2751
2024
Q3 		$86.2K Sell
43,989
-272
-0.6% -$557 ﹤0.01% 2686
2024
Q2 		$72.6K Buy
+44,261
New +$141K ﹤0.01% 2768

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corebridge Financial's CRBU Position: Q2 2025 in Review

Corebridge Financial sold out of Caribou Biosciences (CRBU) in Q2 2025, closing a stake of 40,304 shares — an estimated $36.8K sold.

Corebridge Financial first reported a position in CRBU in Q2 2024 and held it in 4 quarters. The position peaked at $86.2K in Q3 2024. 129 funds tracked by Wall St. Rank hold CRBU as of Q2 2025.

  • Corebridge Financial reported no remaining Caribou Biosciences position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 40,304 Caribou Biosciences shares in Q2 2025, an estimated $36.8K.
  • Corebridge Financial first reported a position in Caribou Biosciences in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Caribou Biosciences position peaked at $86.2K in Q3 2024.
  • 129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.